Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548678 · ClinicalTrials.gov registry record · Phase 1
Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers
A Phase 1 study, sponsored by Javelin Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00548678 is a Phase 1 study that has completed, run by Javelin Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT00548678, a Phase 1 study, has completed, sponsored by Javelin Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will assess platelet function and safety in healthy male volunteers following doses of intravenous diclofenac compared to oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.
Interventions
- DRUG ketorolac
- DRUG aspirin
- DRUG intravenous diclofenac sodium (DIC075V)
- DRUG oral diclofenac (Cataflam)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-10 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00548678
The ClinicalTrials.gov registry entry for NCT00548678 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Javelin Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which ketorolac is the first listed.
NCT00548678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00548678 about?
NCT00548678 is a clinical study titled "Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers". This study will assess platelet function and safety in healthy male volunteers following doses of intravenous diclofenac compared to oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.
What is the current status of trial NCT00548678?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2007-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00548678?
The interventions under investigation include: ketorolac (DRUG), aspirin (DRUG), intravenous diclofenac sodium (DIC075V) (DRUG), oral diclofenac (Cataflam) (DRUG).
Who is sponsoring clinical trial NCT00548678?
This trial is sponsored by Javelin Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.